GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

ilShinBioBase Co 068330.KQ · KRW

Industrials · KOSDAQ · 🇰🇷 South Korea

Compare

953

-0.73%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩14.53bn

FY2016FY2025

Net income

₩4.79bn

FY2016FY2025

Free cash flow

₩5.25bn

FY2016FY2025

Shareholders' equity

₩64.80bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩14.53bn₩10.82bn₩16.44bn₩20.43bn₩24.38bn₩21.04bn₩19.64bn₩15.38bn₩12.84bn₩13.36bn
Gross profit₩7.72bn₩6.28bn₩9.43bn₩10.51bn₩13.11bn₩10.37bn₩10.87bn₩6.94bn₩6.09bn₩6.32bn
Research and development₩745.6m₩627.1m₩637.0m₩608.6m———₩471.7m₩454.8m₩528.8m
Operating income₩4.56bn₩2.26bn₩6.21bn₩5.16bn₩7.78bn₩5.02bn₩5.21bn₩3.04bn₩2.34bn₩3.01bn
Net income₩4.79bn₩3.81bn₩6.23bn₩3.82bn₩6.24bn₩4.48bn₩4.65bn₩3.16bn₩2.10bn₩2.69bn
Diluted earnings per share111.8288.92145.3989.00145.68104.48108.5473.7447.6062.79

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩68.58bn₩63.94bn₩60.62bn₩58.45bn₩56.83bn₩49.55bn₩45.63bn₩39.53bn₩38.49bn₩37.66bn
Cash and short-term investments————₩25.58bn₩20.15bn₩17.56bn₩12.75bn₩11.32bn₩10.06bn
Total liabilities₩3.79bn₩3.49bn₩3.55bn₩4.63bn₩6.36bn₩5.17bn₩5.47bn₩3.81bn₩3.27bn₩4.68bn
Shareholders' equity₩64.80bn₩60.45bn₩57.06bn₩53.82bn₩50.47bn₩44.38bn₩40.16bn₩35.72bn₩35.22bn₩32.98bn
Shares outstanding43m43m43m43m43m43m43m43m44m43m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩5.27bn₩4.12bn₩5.92bn₩2.65bn₩6.74bn₩4.50bn₩5.55bn₩4.88bn₩2.11bn₩3.01bn
Capital spending−₩20.6m−₩53.5m−₩262.2m−₩522.6m−₩139.1m−₩892.6m−₩245.4m−₩385.8m−₩407.6m−₩271.9m
Free cash flow₩5.25bn₩4.07bn₩5.66bn₩2.12bn₩6.61bn₩3.61bn₩5.30bn₩4.49bn₩1.71bn₩2.74bn
Dividends paid−₩291.7m−₩291.7m−₩300.1m−₩300.1m−₩300.1m−₩300.1m−₩214.3m−₩214.3m−₩214.3m−₩214.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩4.17bn₩2.52bn₩4.23bn₩4.87bn₩3.54bn₩1.89bn₩3.89bn₩2.62bn
Gross profit₩2.39bn₩1.31bn₩1.96bn₩2.87bn₩1.82bn₩1.07bn₩2.31bn₩1.66bn
Operating income₩1.53bn₩455.4m₩1.09bn₩1.91bn₩1.12bn₩443.1m₩1.16bn₩375.3m
Net income₩1.65bn₩975.1m₩1.47bn₩1.92bn₩742.4m₩662.4m₩1.91bn₩527.7m
Diluted earnings per share38.4722.7534.1844.8717.3215.4545.8312.66
Cash from operations₩426.0m₩3.46bn₩1.56bn₩2.48bn₩1.15bn₩75.0m——
Capital spending—−₩38.0m—−₩15.0m—−₩55.0m——
Free cash flow—₩3.42bn—₩2.46bn—₩20.0m——
Total assets₩73.81bn₩72.69bn₩68.58bn₩67.48bn₩65.44bn₩64.28bn₩63.94bn₩62.03bn
Cash and short-term investments——————₩37.24bn₩34.32bn
Shareholders' equity₩67.09bn₩65.35bn₩64.80bn₩63.52bn₩61.60bn₩60.82bn₩60.45bn₩58.76bn

Financial ratios

Data as of 14 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015FY2013
Gross margin53.1%58.0%57.4%51.4%53.8%49.3%—————
Operating margin31.4%20.9%37.8%25.3%——26.6%19.7%———
Net margin33.0%35.2%37.9%18.7%25.6%21.3%—————
Return on equity7.4%6.3%10.9%7.1%12.4%10.1%—————
Return on assets7.0%6.0%10.3%6.5%11.0%9.0%—————
Free cash flow yield———————10.9%5.1%——
Revenue growth34.3%-34.2%-19.6%-16.2%15.9%7.1%—————
Earnings growth25.8%-38.8%63.4%-38.9%39.4%-3.7%—————
Current ratio14.82x14.42x13.51x9.31x6.49x6.73x—————
Debt to equity—————————0.02x0.05x
Equity ratio94.5%94.5%94.1%92.1%88.8%89.6%—————
Interest coverage——3107179.15x61446.54x———————
R&D as a share of sales5.1%5.8%3.9%3.0%———3.1%3.5%——
Buybacks as a share of market value———————3.1%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-10.7%-7.1%1.2%
Operating income-4.0%-1.9%6.2%
Net income7.9%1.4%6.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.2%54.5%53.3%51.5%
Operating margin26.9%29.3%28.8%25.9%
Net margin33.9%30.0%27.3%24.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings14.411.69.317.530.675.619.424.148.746.4
Price to sales4.84.13.53.37.816.14.65.08.09.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Dec 2024.

FY2024FY2023FY2022FY2021FY2020FY2019FY2015FY2011
Paid in the year14.007.007.007.007.005.005.004.959
  • 5-for-1 split · 11 Feb 2014
  • 11-for-10 split · 27 Dec 2012
  • 11-for-10 split · 28 Dec 2011
  • 2-for-1 split · 2 Oct 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.